News & Updates
Filter by Specialty:

Should experts rename ‘fatty liver disease’ to reduce stigma?
11 Mar 2024
Individuals with nonalcoholic fatty liver disease (NAFLD) may face stigma from the disease or comorbidities, but the perceptions of shame differ across patients, healthcare providers, geographic locations, and subspecialties, reveals a study.
Should experts rename ‘fatty liver disease’ to reduce stigma?
11 Mar 2024
Novel investigational combo a breakthrough in HIV treatment?
11 Mar 2024
byAudrey Abella
Phase II data presented at CROI 2024 demonstrated the ability of an investigational, long-acting, oral once-weekly regimen comprising islatravir, a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class capsid inhibitor, to maintain viral suppression at week 24 in virologically suppressed people living with HIV (PWH).